-
On a path to accelerate access to Ebola vaccines: The WHO’s research and development efforts during the 2014-2016 Ebola epidemic in West Africa.
May 19, 2016 Editor 0
Related Articles On a path to accelerate access to Ebola vaccines: The WHO’s research and development efforts during the 2014-2016 Ebola epidemic in West Africa.
Curr Opin Virol. 2016 May 12;17:138-144
Authors: Henao-Restrepo AM, Preziosi MP, Wood D, Moorthy V, Kieny MP, WHO Ebola Research, Development Team
Abstract
During 2014 and 2015 an outbreak of Ebola deemed a Public Health Emergency of International Concern affected a number of West African countries. The outbreak underscored the need for a vaccine against Ebola. An unprecedented and to great extent collaborative effort built on the availability of a number of candidate vaccines that could enter into clinical phase evaluation. A series of international consultations and activities were led by WHO as a contribution to the unprecedented global efforts to develop and assess an Ebola vaccine. WHO consulted widely, and immediately fostered interactions with the international scientific, ethics, regulatory, vaccine development, public health partners, industry and funders’ communities and participated in consortia to facilitate Ebola vaccine assessments. WHO also fostered key activities to ensure the optimal policy and deployment of Ebola vaccines, if licensed. WHO has convened a broad global coalition of experts to develop a Blueprint and a platform for accelerated R&D, in order to avert full-blown epidemics.PMID: 27180074 [PubMed – as supplied by publisher]
Related Posts
The Role of Public Knowledge, Resources, and Innovation in Responding to the Ebola Outbreak.
Collaborative development and implementation of a knowledge brokering program to promote research use in Burkina Faso, West Africa.
Innovative clinical trial designs to rationalize TB vaccine development.
From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project.
NIH-sponsored HIV vaccine trial launches in South Africa
First results from Phase 3 trial show malaria vaccine candidate reduces the risk of malaria
Categories: Health
Tags: Ebola vaccines
An innovation for improving maternal, newborn and child health (MNCH) service delivery in Jigawa State, northern Nigeria: a qualitative study of stakeholders’ perceptions about clinical mentoring. Innovation in health service delivery: integrating community health assistants into the health system at district level in Zambia.
Subscribe to our stories
Recent Posts
- Prize-winning projects promote healthier eating, smarter crop investments June 28, 2018
- Reliable energy for all June 28, 2018
- Making marble from bottles: plastic waste’s second life in Kenya June 28, 2018
- A regional enterprise to commercialize an integrated technology for waste water treatment and biowaste conversion in eastern Africa May 27, 2018
- Dr Peggy Oti-Boateng May 27, 2018
Categories
Archives
Popular Post-All time
- Test Your Value Propositi... 371 views
- A review on biomass-based... 325 views
- NASAC statement on the oc... 232 views
- Nano ‘tea bag’... 228 views
- New ‘biofactories... 224 views